Cvs Health Corp Stock Debt To Equity
| CVS Stock | EUR 56.21 1.00 1.75% |
CVS Health Corp fundamentals help investors to digest information that contributes to CVS Health's financial success or failures. It also enables traders to predict the movement of CVS Stock. The fundamental analysis module provides a way to measure CVS Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CVS Health stock.
CVS |
CVS Health Corp Company Debt To Equity Analysis
CVS Health's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current CVS Health Debt To Equity | 149.20 % |
Most of CVS Health's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, CVS Health Corp has a Debt To Equity of 149%. This is 178.67% higher than that of the Healthcare sector and 124.26% higher than that of the Health Care Plans industry. The debt to equity for all Germany stocks is notably lower than that of the firm.
CVS Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Health's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Health could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics of similar companies.CVS Health is currently under evaluation in debt to equity category among its peers.
CVS Fundamentals
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 173.98 B | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 82.27 % | |||
| Price To Earning | 14.93 X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 0.39 X | |||
| Revenue | 322.47 B | |||
| Gross Profit | 53.46 B | |||
| EBITDA | 12.16 B | |||
| Net Income | 4.15 B | |||
| Cash And Equivalents | 8.53 B | |||
| Cash Per Share | 6.55 X | |||
| Total Debt | 50.48 B | |||
| Debt To Equity | 149.20 % | |||
| Current Ratio | 0.95 X | |||
| Book Value Per Share | 54.63 X | |||
| Cash Flow From Operations | 16.18 B | |||
| Earnings Per Share | 2.96 X | |||
| Price To Earnings To Growth | 1.35 X | |||
| Number Of Employees | 219 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 101.03 B | |||
| Total Asset | 228.28 B | |||
| Z Score | 2.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.11 % | |||
| Net Asset | 228.28 B | |||
| Last Dividend Paid | 2.2 |
About CVS Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CVS Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CVS Stock
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.